Clinical Trials Browser

Phase 2/3 × Unknown × Lung Neoplasms × Clear all

NCT05994339 2023-08-29

Radiotherapy Combined With Almonertinib for Stage III EGFR-Mutated Lung Cancer

Phase 2/3 Unknown

Lung Neoplasms

NCT03380468 2023-07-20

ECTOP-1004

Phase 2/3 Unknown

Adenocarcinoma of Lung, Lung Neoplasms

NCT04942275 2022-09-19

PEGASUS

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01407822 2018-09-11

EMERGING

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03384667 2018-02-28

Maekmoondong-tang on Post-operative Cough in Patients With Lung Cancer

Phase 2/3 Unknown

Lung Neoplasms

NCT01782287 2017-10-12

Proteome-based Immunotherapy of Lung Cancer Brain Metastases

Phase 2/3 Unknown

Brain Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT02393664 2015-07-03

Effects of Nonintubated Versus Intubated General Anesthesia on Recovery After Thoracoscopic Lung Resection

Phase 2/3 Unknown

Lung Neoplasms

NCT02350361 2015-01-29

Endostar Combination With Chemotherapy and EGFR-TKI in Lung Cancer Rechallenging Treatment After Acquired Resistance.

Phase 2/3 Unknown

Lung Neoplasms

NCT00030641 2014-01-06

Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00022009 2013-09-20

Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2/3 Unknown

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01731548 2013-01-23

A Prospective Randomized Study Comparing the Target Volume for Limited-stage Small Cell Lung Cancer

Phase 2/3 Unknown

Lung Neoplasms

NCT01048970 2010-01-14

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

Phase 2/3 Unknown

Lung Neoplasms, Weight Loss